Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures

Breast Cancer & the Environment Research Program

University of Massachusetts, Amherst
University of Massachusetts Medical School - Baystate Health

Principal Investigators:
D. Joseph Jerry, Ph.D.
Sally S. Schneider, Ph.D.

NIEHS Grant: U01ES26140

Other Community and Academic Partners:
UMass Center for Clinical and Translational Science
The Rays of Hope Center for Breast Cancer Research
La Esperanza
Girls Inc. of the Valley

Parity, or the number of times a woman carries pregnancies to a viable gestational age, engages pathways within the breast epithelium that render it resistant to carcinogenesis. These pathways are potent as parity reduces the risk associated with carcinogens and inherited risk alleles, preventing as many as 70,000 cases of breast cancer annually. The levels of estrogens during pregnancy are sufficient to mimic the protective effects of parity. The actions of estrogens are mediated by two estrogen receptor subtypes, ERα and Erβ, that balance their competing effects on proliferation and growth suppression mediated by the p53 tumor suppressor pathway. Pregnancy also suppresses WNT/β-catenin signaling and reduces the pool of vulnerable stem cells within the mammary epithelium. However, chronic exposure to exogenous chemicals that mimic estrogen, or xenoestrogens, erodes the protective effects of pregnancy in rodents.

During pregnancy, women are exposed to high levels of xenoestrogens such as benzophenones, parabens, phthalates, and these differ in their potencies for ERα and ERβ. Therefore, pregnancy is a critical window during which xenoestrogens may disrupt tumor suppressor pathways and render the breast epithelium susceptible to carcinogenesis. In these experiments, researchers are testing four xenoestrogens that are abundant in pregnant women and differ in potency for ERα and ERβ. Parallel experiments in primary breast tissues and mouse models are used to determine whether xenoestrogens interfere with the effects of pregnancy on critical tumor suppressor pathways.

Researchers are also using breast epithelial cells to determine the effects of xenoestrogens on tumor suppressor pathways and the variation in responses among women. Dose-response relationships for each xenoestrogen will be determined in MCF-7 breast cancer cells expressing either ERα or both ERα+ERβ. Primary cultures of normal breast epithelial cells are used to confirm responses and define subsets of women who are highly sensitive or resistant to xenoestrogens. They then compare effects of xenoestrogens in explant cultures of breast tissue and in BALB/c mice. Parallel treatments in these mice will help validate the in vivo model and determine effects of chronic exposures to xenoestrogens on tumor suppressor pathways. Researchers also are testing the effects of xenoestrogens on tumorigenesis. The ability of xenoestrogens to cause progression of premalignant cells is being tested using transplants of CDβGeo cells. The ability of xenoestrogens to reverse the protective effect of parity will be tested in mice bearing transplants of Trp53+/- mammary epithelium.

Community partners provide a means to dynamically communicate the concerns of the community and results from research. Importantly, the experiments are designed to identify a subset of women who may be especially vulnerable to xenoestrogens and demonstrate the relevance of the mouse models to human exposures.

to Top